The Human Protein Atlas database has shown that the survival rate of patients with cancers of lower FOXO1 expression is shorter than those of patients with cancers of higher FOXO1 expression in colorectal, renal, and hepatic adenocarcinomas [112,113,114]. Here, FOXO1 is linked to cancer.